No evidence of significant cross-reactivity between the dengue virus (DENV) and SARS-CoV-2 IgG antibodies
Farah M. Shurrab, Fatima Humaira, Enas S. Al-Absi, Duaa W. Al-Sadeq, Hamda Qotba, Hadi. M. Yassine, Laith J. Abu-Raddad, View ORCID ProfileGheyath K. Nasrallah
doi: https://doi.org/10.1101/2021.04.19.21255725
Farah M. Shurrab
1Biomedical Research Center, Qatar University, Doha 2713, Qatar
Fatima Humaira
1Biomedical Research Center, Qatar University, Doha 2713, Qatar
Enas S. Al-Absi
1Biomedical Research Center, Qatar University, Doha 2713, Qatar
Duaa W. Al-Sadeq
1Biomedical Research Center, Qatar University, Doha 2713, Qatar
2College of Medicine, Member of QU Health, Qatar University, 2713, Doha, Qatar
Hamda Qotba
3Department of Clinical Research, Primary Health Care Centers, 26555, Doha, Qatar
Hadi. M. Yassine
1Biomedical Research Center, Qatar University, Doha 2713, Qatar
4Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, 2713, Doha, Qatar
Laith J. Abu-Raddad
5Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
6World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
7Department of Healthcare Policy and Research, Weill Cornell Medicine, Cornell University, New York, United States of America
Gheyath K. Nasrallah
1Biomedical Research Center, Qatar University, Doha 2713, Qatar
4Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, 2713, Doha, Qatar
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted April 22, 2021.
No evidence of significant cross-reactivity between the dengue virus (DENV) and SARS-CoV-2 IgG antibodies
Farah M. Shurrab, Fatima Humaira, Enas S. Al-Absi, Duaa W. Al-Sadeq, Hamda Qotba, Hadi. M. Yassine, Laith J. Abu-Raddad, Gheyath K. Nasrallah
medRxiv 2021.04.19.21255725; doi: https://doi.org/10.1101/2021.04.19.21255725
No evidence of significant cross-reactivity between the dengue virus (DENV) and SARS-CoV-2 IgG antibodies
Farah M. Shurrab, Fatima Humaira, Enas S. Al-Absi, Duaa W. Al-Sadeq, Hamda Qotba, Hadi. M. Yassine, Laith J. Abu-Raddad, Gheyath K. Nasrallah
medRxiv 2021.04.19.21255725; doi: https://doi.org/10.1101/2021.04.19.21255725
Subject Area
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12175)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3832)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)